Dr. Reddy’s launches Nexavar generic in the US

BL Hyderabad Bureau | | Updated on: Jun 14, 2022
The Dr. Reddy’s Laboratories Ltd campus in Hyderabad

The Dr. Reddy’s Laboratories Ltd campus in Hyderabad | Photo Credit: Srikrishnan P C@Chennai

The drug is used to treat certain types of cancer

Dr. Reddy’s Laboratories Ltd has launched sorafenib tablets, a therapeutic generic equivalent of Nexavar (sorafenib) in the US market following approval by the US Food and Drug Administration (USFDA). The drug is used to treat certain types of cancer. 

“We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories Inc, said in a release. 

The drug is available as 200 mg tablets in a bottle of 120.

Published on June 14, 2022
COMMENTS
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you